Exercise Training on Gait Pattern in Pregnancy
- Disease/Condition
- Pregnancy
- Drug/Device/Intervention
- Walk exercise
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- Ege University
- Location
- İzmir, Turkey
- Phase
- N/A
- Start date
- May 01, 2022
- End date
- Jan 28, 2023
- Enrollment
- 104 participants
Foot plantar pressure
The research will be conducted with healthy pregnant women who applied to the Ege University
 Gynecology and Obstetrics Department Polyclinic, and were referred to the Sports Medicine
 Department.The study will consist of two groups as the control group and the exercise
 group.Voluntary pregnant women who are not found to be inconvenient to do moderate-intensity
 exercise by the doctor will participate in the study.The study was planned as a randomized
 controlled and single-blind study.The participant's demographic information, obstetric
 assessment, physical activity level, fall history and pain assessment will be recorded.Foot
 plantar pressure, static and dynamic balance, center of pressure (COP), subtalar joint
 evaluation and gait evaluation will be measured by pedobarography at Ege University
 Orthopedics and Traumatology Department Gait Laboratory.The control group will be offered
 walking as recommended by ACOG for pregnant women.Clinical exercise training will be given to
 pregnant women in the study group by a specialist physiotherapist.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05481983
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05481983 through Pure Global AI's free database. This phase not specified trial is sponsored by Ege University and is currently Enrolling by invitation. The study focuses on Pregnancy. Target enrollment is 104 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.